PMID- 38464135 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240320 DP - 2024 Feb 19 TI - Metformin Enhances Antibody-Mediated Recognition of HIV-Infected CD4(+) T-Cells by Decreasing Viral Release. LID - 2024.02.15.580166 [pii] LID - 10.1101/2024.02.15.580166 [doi] AB - The mechanistic target of rapamycin (mTOR) positively regulates multiple steps of the HIV-1 replication cycle. We previously reported that a 12-weeks supplementation of antiretroviral therapy (ART) with metformin, an indirect mTOR inhibitor used in type-2 diabetes treatment, reduced mTOR activation and HIV transcription in colon-infiltrating CD4(+) T-cells, together with systemic inflammation in nondiabetic people with HIV-1 (PWH). Herein, we investigated the antiviral mechanisms of metformin. In a viral outgrowth assay performed with CD4(+) T-cells from ART-treated PWH, and upon infection in vitro with replication-competent and VSV-G-pseudotyped HIV-1, metformin decreased virion release, but increased the frequency of productively infected CD4(low)HIV-p24(+) T-cells. These observations coincided with increased BST2/Tetherin (HIV release inhibitor) and Bcl-2 (pro-survival factor) expression, and improved recognition of productively infected T-cells by HIV-1 Envelope antibodies. Thus, metformin exerts pleiotropic effects on post-transcription/translation steps of the HIV-1 replication cycle and may be used to accelerate viral reservoir decay in ART-treated PWH. FAU - Fert, Augustine AU - Fert A AD - Centre de recherche du Centre hospitalier de l'Universite de Montreal, Montreal, QC, H2X 0A9, Canada. AD - Departement de microbiologie, infectiologie et immunologie, Faculte de medecine, Universite de Montreal, Montreal, QC, H3C 3J7, Canada. FAU - Richard, Jonathan AU - Richard J AD - Centre de recherche du Centre hospitalier de l'Universite de Montreal, Montreal, QC, H2X 0A9, Canada. AD - Departement de microbiologie, infectiologie et immunologie, Faculte de medecine, Universite de Montreal, Montreal, QC, H3C 3J7, Canada. FAU - Marchand, Laurence Raymond AU - Marchand LR AD - Centre de recherche du Centre hospitalier de l'Universite de Montreal, Montreal, QC, H2X 0A9, Canada. FAU - Planas, Delphine AU - Planas D AD - Centre de recherche du Centre hospitalier de l'Universite de Montreal, Montreal, QC, H2X 0A9, Canada. AD - Departement de microbiologie, infectiologie et immunologie, Faculte de medecine, Universite de Montreal, Montreal, QC, H3C 3J7, Canada. FAU - Routy, Jean-Pierre AU - Routy JP AD - Infectious Diseases and Immunity in Global Health Program, Research Institute, McGill University Health Centre, Montreal, QC, Canada. AD - Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada. AD - Division of Hematology, McGill University Health Centre, Montreal, QC, Canada. FAU - Chomont, Nicolas AU - Chomont N AUID- ORCID: 0000-0001-9747-5018 AD - Centre de recherche du Centre hospitalier de l'Universite de Montreal, Montreal, QC, H2X 0A9, Canada. AD - Departement de microbiologie, infectiologie et immunologie, Faculte de medecine, Universite de Montreal, Montreal, QC, H3C 3J7, Canada. FAU - Finzi, Andres AU - Finzi A AD - Centre de recherche du Centre hospitalier de l'Universite de Montreal, Montreal, QC, H2X 0A9, Canada. AD - Departement de microbiologie, infectiologie et immunologie, Faculte de medecine, Universite de Montreal, Montreal, QC, H3C 3J7, Canada. FAU - Ancuta, Petronela AU - Ancuta P AUID- ORCID: 0000-0003-1922-5640 AD - Centre de recherche du Centre hospitalier de l'Universite de Montreal, Montreal, QC, H2X 0A9, Canada. AD - Departement de microbiologie, infectiologie et immunologie, Faculte de medecine, Universite de Montreal, Montreal, QC, H3C 3J7, Canada. AD - Lead Contact. LA - eng GR - R01 AI148379/AI/NIAID NIH HHS/United States GR - R01 AI150322/AI/NIAID NIH HHS/United States GR - UM1 AI164560/AI/NIAID NIH HHS/United States GR - UM1 AI164562/AI/NIAID NIH HHS/United States PT - Preprint DEP - 20240219 PL - United States TA - bioRxiv JT - bioRxiv : the preprint server for biology JID - 101680187 PMC - PMC10925111 COIS- CONFLICT OF INTEREST The authors declare no competing interests. EDAT- 2024/03/11 06:43 MHDA- 2024/03/11 06:44 PMCR- 2024/03/10 CRDT- 2024/03/11 04:31 PHST- 2024/03/11 06:43 [pubmed] PHST- 2024/03/11 06:44 [medline] PHST- 2024/03/11 04:31 [entrez] PHST- 2024/03/10 00:00 [pmc-release] AID - 2024.02.15.580166 [pii] AID - 10.1101/2024.02.15.580166 [doi] PST - epublish SO - bioRxiv [Preprint]. 2024 Feb 19:2024.02.15.580166. doi: 10.1101/2024.02.15.580166.